Kymera Therapeutics (KYMR) Shares Outstanding: 2019-2025
Historic Shares Outstanding for Kymera Therapeutics (KYMR) over the last 6 years, with Sep 2025 value amounting to $71.7 million.
- Kymera Therapeutics' Shares Outstanding rose 10.80% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.7 million, marking a year-over-year increase of 10.80%. This contributed to the annual value of $64.9 million for FY2024, which is 16.74% up from last year.
- According to the latest figures from Q3 2025, Kymera Therapeutics' Shares Outstanding is $71.7 million, which was up 1.68% from $70.6 million recorded in Q2 2025.
- Kymera Therapeutics' 5-year Shares Outstanding high stood at $71.7 million for Q3 2025, and its period low was $44.9 million during Q1 2021.
- Moreover, its 3-year median value for Shares Outstanding was $61.6 million (2024), whereas its average is $62.0 million.
- Data for Kymera Therapeutics' Shares Outstanding shows a peak YoY spiked of 2,171.44% (in 2021) over the last 5 years.
- Kymera Therapeutics' Shares Outstanding (Quarterly) stood at $51.5 million in 2021, then grew by 6.80% to $55.0 million in 2022, then grew by 0.99% to $55.6 million in 2023, then rose by 16.74% to $64.9 million in 2024, then rose by 10.80% to $71.7 million in 2025.
- Its Shares Outstanding stands at $71.7 million for Q3 2025, versus $70.6 million for Q2 2025 and $65.1 million for Q1 2025.